Malignant Testicular Neoplasm — Trials

Malignant Testicular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 26
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: University Health Network, Toronto
Termination share: 34.6%
Trials / 1,000 deaths: 80.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–29 of 29 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00183820	Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma	completed	Phase 2	30	University of Southern CaliforniaOTHER	1	Jul 1, 2026	clinicaltrials
NCT02213913	Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas	completed	Phase 1 / Phase 2	55	University of ChicagoOTHER	1	Mar 11, 2026	clinicaltrials